Showing 541-560 of 644 for: Cochrane Systematic Reviews > Respiratory 
- Rifabutin for treating pulmonary tuberculosis
Cochrane Systematic Reviews, 10-Nov-2009
Rifamycins are an essential component of modern short-course regimens for treating tuberculosis. Rifabutin has favourable pharmacokinetic and pharmacodynamic properties and is less prone to drug-drug interactions than rifampicin. It could contribute to sh
- Routine surgery in addition to chemotherapy for treating spinal tuberculosis
Cochrane Systematic Reviews, 25-Jan-2006
Tuberculosis is generally curable with chemotherapy, but there is controversy in the literature about the need for surgical intervention in the one to two per cent of people with tuberculosis of the spine.
- Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews
Cochrane Systematic Reviews, 17-Oct-2012
Two large surveillance studies in adults with asthma have found an increased risk of asthma-related mortality in those who took regular salmeterol as monotherapy in comparison to placebo or regular salbutamol. No similar sized surveillance studies have be
- Saline nasal irrigation for acute upper respiratory tract infections
Cochrane Systematic Reviews, 20-Apr-2015
Acute upper respiratory tract infections (URTIs), including the common cold and rhinosinusitis, are common afflictions that cause discomfort and debilitation and contribute significantly to workplace absenteeism. Treatment is generally by antipyretic and
- Screening for lung cancer
Cochrane Systematic Reviews, 18-Jun-2013
This is an updated version of the original review published in The Cochrane Library in 1999 and updated in 2004 and 2010. Population-based screening for lung cancer has not been adopted in the majority of countries. However it is not clear whether sputum
- Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease
Cochrane Systematic Reviews, 8-Mar-2012
Randomized trials have demonstrated that adding a drug to a single-agent or to a two-agent regimen increased the tumor response rate in patients with advanced non-small cell lung cancer (NSCLC), although its impact on survival remains controversial.
- Second‐line chemotherapy for non‐small cell lung cancer
Cochrane Systematic Reviews, 22-Apr-2002
The role of second-line chemotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) who have relapsed or failed to respond to first-line treatment was unclear.
- Selenium supplementation for asthma
Cochrane Systematic Reviews, 29-Sep-2008
Selenium deficiency may be important in chronic asthma. Observational studies have demonstrated that patients with chronic asthma may have lower levels of selenium than their control. Nevertheless, selenium supplementation has not been recommended with dr
- Self‐management education and regular practitioner review for adults with asthma
Cochrane Systematic Reviews, 22-Jul-2002
A key component of many asthma management guidelines is the recommendation for patient education and regular medical review. A number of controlled trials have been conducted to measure the effectiveness of asthma education programmes. These programmes im
- Self‐management education for cystic fibrosis
Cochrane Systematic Reviews, 8-Sep-2014
Self-management education may help patients with cystic fibrosis and their families to choose, monitor and adjust treatment requirements for their illness, and also to manage the effects of illness on their lives. Although self-management education interv
- Self‐management interventions for people with chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 10-Jan-2022
Self-management interventions help people with chronic obstructive pulmonary disease (COPD) to acquire and practise the skills they need to carry out disease-specific medical regimens, guide changes in health behaviour and provide emotional support to ena
- Short acting beta2-agonists for bronchiectasis
Cochrane Systematic Reviews, 13-May-2008
Bronchiectasis is a condition characterized by an abnormal and irreversible dilatation of the sub segmental airways and it may be caused by a variety of disease processes. Currently medical treatment includes physiotherapy, antibiotics and occasionally mu
- Short acting beta2‐agonists for recurrent wheeze in children under two years of age
Cochrane Systematic Reviews, 22-Apr-2002
Wheeze is a common symptom in infancy and is a common cause for both primary care consultations and hospital admission. Beta2-adrenoceptor agonists (b2-agonists) are the most frequently used as bronchodilator but their efficacy is questionable.
- Short courses of antibiotics for children and adults with bronchiectasis
Cochrane Systematic Reviews, 31-Mar-2011
Bronchiectasis is an important cause of respiratory morbidity in both developing and developed countries. Antibiotics are considered standard therapy in the treatment of this condition but it is unknown whether short courses (four weeks or less) are effic
- Short‐acting beta2‐agonists for stable chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 22-Jul-2002
Chronic Obstructive Pulmonary Disease (COPD) is a chronic condition characterised by progressive airflow limitation that is at most partially reversible. Despite the lack of reversibility patients often report symptomatic improvement with short-acting bet
- Short‐course antibiotics for acute otitis media
Cochrane Systematic Reviews, 8-Sep-2010
Acute otitis media (AOM) is a common illness during childhood, for which antibiotics are frequently prescribed.
- Short‐course versus long‐course antibiotic therapy for non‐severe community‐acquired pneumonia in children aged 2 months to 59 months
Cochrane Systematic Reviews, 23-Apr-2008
Pneumonia is the leading cause of mortality in children under five years of age. Treatment of pneumonia requires an effective antibiotic used in adequate doses for an appropriate duration. Recommended duration of treatment ranges between 7 and 14 days, bu
- Short-term ambulatory oxygen for chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 21-Aug-2008
Ambulatory oxygen is defined as the use of supplemental oxygen during exercise and activities of daily living. Ambulatory oxygen therapy is often used for patients on long term oxygen therapy during exercise, or for non long term oxygen therapy users who
- Sildenafil for pulmonary hypertension in neonates
Cochrane Systematic Reviews, 4-Aug-2017
Persistent pulmonary hypertension in the neonate (PPHN) is associated with high mortality. Currently, the therapeutic mainstay for PPHN consists of assisted ventilation and administration of inhaled nitric oxide (iNO). However, nitric oxide is costly, and
- Simple aspiration versus intercostal tube drainage for primary spontaneous pneumothorax in adults
Cochrane Systematic Reviews, 7-Sep-2017
For management of pneumothorax that occurs without underlying lung disease, also referred to as primary spontaneous pneumothorax, simple aspiration is technically easier to perform than intercostal tube drainage. In this systematic review, we seek to comp
